Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Lovastatin suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 22/February/2014, 22.02

Therapeutic insights into Metastasis suppression: Berberine suppresses the expression of metastasis promoter MMP2 via up regulation of its target gene, 22/February/2014, 21.47
February 22, 2014
Insights into Molecular cancer therapy: NOS-2 suppresses the expression of pro-apoptotic protein BTG2 via up regulation of its target gene, 22/February/2014, 22.13
February 22, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Lovastatin suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 22/February/2014, 22.02, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.